Condition: Kidney Disease

The purpose of the study is to evaluate the dose-response efficacy, safety, and pharmacokinetics (PK) of AZD5718 compared to placebo in participants with proteinuric chronic kidney disease (CKD).

Location(s): Macon

Condition: Kidney Disease